Works matching IS 00316970 AND DT 2016 AND VI 72 AND IP 10

Results: 15

Levobupivacaine absorption pharmacokinetics with and without epinephrine during TAP block: analysis of doses based on the associated risk of local anaesthetic toxicity.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 10, p. 1221, doi. 10.1007/s00228-016-2086-1

By:

Miranda, P.;
Corvetto, M.;
Altermatt, Fernando;
Araneda, A.;
Echevarría, G.;
Cortínez, L.

Publication type:

Article

Ibuprofen-associated hypothermia in children: analysis of the Italian spontaneous reporting database.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 10, p. 1239, doi. 10.1007/s00228-016-2088-z

By:

Donati, Monia;
Monaco, Luca;
Melis, Mauro;
Sottosanti, Laura;
Biagi, Chiara;
Vaccheri, Alberto;
Motola, Domenico

Publication type:

Article

Evaluating patients' comprehensibility of a standardized medication plan.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 10, p. 1229, doi. 10.1007/s00228-016-2082-5

By:

Botermann, Lea;
Monzel, Katharina;
Krueger, Katrin;
Eickhoff, Christiane;
Wachter, Angelika;
Kloft, Charlotte;
Laufs, Ulrich;
Schulz, Martin

Publication type:

Article

Effect of prehospital epinephrine on out-of-hospital cardiac arrest: a report from the national out-of-hospital cardiac arrest data registry in Japan, 2011-2012.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 10, p. 1255, doi. 10.1007/s00228-016-2093-2

By:

Fukuda, Tatsuma;
Ohashi-Fukuda, Naoko;
Matsubara, Takehiro;
Gunshin, Masataka;
Kondo, Yutaka;
Yahagi, Naoki

Publication type:

Article

Effect of cytochrome P450 2C19 polymorphisms on the clinical outcomes of voriconazole: a systematic review and meta-analysis.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 10, p. 1185, doi. 10.1007/s00228-016-2089-y

By:

Li, Xiaofei;
Yu, Caiyuan;
Wang, Tiansheng;
Chen, Ken;
Zhai, Suodi;
Tang, Huilin

Publication type:

Article

Risk factors for hypernatremia in patients with short- and long-term tolvaptan treatment.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 10, p. 1177, doi. 10.1007/s00228-016-2091-4

By:

Hirai, Keita;
Shimomura, Tatsuki;
Moriwaki, Hideaki;
Ishii, Hidetoshi;
Shimoshikiryo, Takayuki;
Tsuji, Daiki;
Inoue, Kazuyuki;
Kadoiri, Toshihiko;
Itoh, Kunihiko

Publication type:

Article

Do the EMA accelerated assessment procedure and the FDA priority review ensure a therapeutic added value? 2006-2015: a cohort study.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 10, p. 1275, doi. 10.1007/s00228-016-2104-3

By:

Boucaud-Maitre, Denis;
Altman, Jean-Jacques

Publication type:

Article

Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders -a pharmacoepidemiological study and clinical implications.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 10, p. 1245, doi. 10.1007/s00228-016-2092-3

By:

Baftiu, Arton;
Johannessen Landmark, Cecilie;
Rusten, Ida;
Feet, Silje;
Johannessen, Svein;
Larsson, Pål

Publication type:

Article

Impact of genetic polymorphisms related to clopidogrel or acetylsalicylic acid pharmacology on clinical outcome in Chinese patients with symptomatic extracranial or intracranial stenosis.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 10, p. 1195, doi. 10.1007/s00228-016-2094-1

By:

Zhao, Zhigang;
Li, Xingang;
Sun, Shusen;
Mei, Shenghui;
Ma, Ning;
Miao, Zhongrong;
Zhao, Ming;
Peng, Shiqi

Publication type:

Article

The P450 oxidoreductase (POR) rs2868177 and cytochrome P450 (CYP) 2B6*6 polymorphisms contribute to the interindividual variability in human CYP2B6 activity.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 10, p. 1205, doi. 10.1007/s00228-016-2095-0

By:

Gao, Li-Chen;
Liu, Fang-Qun;
Yang, Li;
Cheng, Lin;
Dai, Hai-Ying;
Tao, Ran;
Cao, Shi-Peng;
Wang, Di;
Tang, Jie

Publication type:

Article

Biosimilar erythropoiesis-stimulating agents and the risk of developing anti-drug antibodies-a systematic review.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 10, p. 1161, doi. 10.1007/s00228-016-2096-z

By:

Arnlind, Marianne;
Fryklund, Linda;
Vitols, Sigurd;
Bertilsson, Göran

Publication type:

Article

Use of cardioselective β-blockers and overall death and cardiovascular outcomes in patients with COPD: a population-based cohort study.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 10, p. 1265, doi. 10.1007/s00228-016-2097-y

By:

Dong, Yaa-Hui;
Chang, Chia-Hsuin;
Wu, Li-Chiu;
Lai, Mei-Shu

Publication type:

Article

Serotonin transporter gene ( SLC6A4) polymorphisms are associated with response to fluoxetine in south Indian major depressive disorder patients.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 10, p. 1215, doi. 10.1007/s00228-016-2099-9

By:

Manoharan, Aarthi;
Shewade, Deepak;
Rajkumar, Ravi;
Adithan, Surendiran

Publication type:

Article

Statin-induced myopathy in a usual care setting-a prospective observational study of gender differences.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 10, p. 1171, doi. 10.1007/s00228-016-2105-2

By:

Skilving, Ilona;
Eriksson, Mats;
Rane, Anders;
Ovesjö, Marie-Louise

Publication type:

Article

Prevention of selective outcome reporting: let us start from the beginning.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 10, p. 1283, doi. 10.1007/s00228-016-2112-3

By:

Dal-Ré, Rafael;
Marušić, Ana

Publication type:

Article